2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study

计划入组 40 人 · 首次发布于 2008 年 10 月 3 日

Phase 2b Controlled Study

计划入组 30 人 · 首次发布于 2025 年 8 月 24 日

CALM Phase 2b Pilot

计划入组 60 人 · 首次发布于 2015 年 2 月 2 日

ACVR2A inhibitors(Supercede Therapeutics)

C2-2b-2b

1R-2b

Tarsus Pharmaceuticals

United States

Veru Inc

United States

Acerta Pharma BV

Netherlands

Harbour BioMed's AI-Designed LET003 Shows Superior Obesity Treatment Potential in Preclinical Studies

Harbour BioMed Reports Seventh Consecutive Profitable Half-Year, Driven by Strategic Collaborations and AI-Enabled Pipeline Advances

Ropeginterferon Alfa-2b Shows Promise in Polycythemia Vera Treatment